Horizon Pharma PLC (NASDAQ:HZNP) Receives Notice of Allowance From U.S. Trademark And Patent Office

Horizon Pharma PLC (NASDAQ:HZNP) has announced that it has received a notice of allowance from the U.S. Trademark and Patent Office. It is a well-known specialty biopharmaceutical company with the primary objective of improving the lives of patients by offering different products and services. Management’s Call On The Notice of Allowance: Horizon Pharma is active […]